Francoise Boubert, MD
Obstetrics & Gynecology · Cheshire, CTNPI 1730343542
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $967 of the $1,174 with a category attached, or 82.3%. It is spread thinly across 13 manufacturers, the largest accounting for just 19.3% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $495 and has fallen 70.2% since, to $147 in 2025.
Across 30 payments — averaging $39.15 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$227
- Exeltis, USA Inc.$211
- AbbVie$177
- Sumitomo Pharma America, Inc.$122
- Bayer$120
- AMAG Pharmaceuticals, Inc.$85
- plus $233 from 7 others
What the payments were for
- Speaking & faculty fees$12210%
- Food & beverage$96782%
- Education$857%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 2 | $227 |
| Exeltis, USA Inc. | 4 | $211 |
| AbbVie(2 entities) | 5 | $177 |
| Sumitomo Pharma America, Inc. | 1 | $122 |
| Bayer | 6 | $120 |
| AMAG Pharmaceuticals, Inc. | 4 | $85 |
| Biogen | 1 | $72 |
| Astellas Pharma US Inc | 1 | $57 |
| Coopersurgical, Inc. | 2 | $40 |
| Urovant Sciences Inc | 1 | $21 |
| Pfizer | 1 | $16 |
| Organon | 1 | $14 |
| Mayne Pharma Commercial LLC | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Slynd$162
- DIREXION$125
- GEMTESA$122
- GENERAL EMBOLICS$102
How this compares
$1,174 in reported general payments places this provider in the 70th percentile of 605 obstetrics & gynecology providers in Connecticut.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| YuvafemEstradiol | 19 | $2,440 |
| Estradiol | 38 | $1,812 |
| Estradiol (Twice Weekly)Estradiol | 13 | $399 |
| Nystatin | 18 | $191 |
Paid to pharmacies, not to this prescriber.
Other obstetrics & gynecology in Cheshire
- Mary MinkinNew Haven$285K
- Alessandro SantinNew Haven$98K
- Frederick RauHartford$89K
- Peter AuerbachGroton$41K
- Shieva GhofranyStamford$33K
- Mark LeondiresNorwalk$31K
- Alan FineHartford$30K
- Sean FlahertyHamden$28K
- Adam SteinbergHartford$23K
- Sarp AkselStamford$22K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.